Financial Review: Oncology Institute (NASDAQ:TOI) vs. Auna (NYSE:AUNA)

Oncology Institute (NASDAQ:TOIGet Free Report) and Auna (NYSE:AUNAGet Free Report) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their analyst recommendations, institutional ownership, dividends, earnings, risk, valuation and profitability.

Insider & Institutional Ownership

36.9% of Oncology Institute shares are held by institutional investors. 13.1% of Oncology Institute shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Analyst Ratings

This is a breakdown of current recommendations for Oncology Institute and Auna, as reported by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Oncology Institute 0 0 1 0 3.00
Auna 0 0 4 0 3.00

Oncology Institute presently has a consensus target price of $2.25, indicating a potential upside of 95.65%. Auna has a consensus target price of $14.15, indicating a potential upside of 100.42%. Given Auna’s higher probable upside, analysts plainly believe Auna is more favorable than Oncology Institute.

Profitability

This table compares Oncology Institute and Auna’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Oncology Institute -24.56% -80.46% -28.14%
Auna N/A N/A N/A

Earnings and Valuation

This table compares Oncology Institute and Auna’s top-line revenue, earnings per share and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Oncology Institute $324.24 million 0.26 -$83.07 million ($0.92) -1.25
Auna $3.88 billion 0.13 N/A N/A N/A

Auna has higher revenue and earnings than Oncology Institute.

Summary

Auna beats Oncology Institute on 6 of the 9 factors compared between the two stocks.

About Oncology Institute

(Get Free Report)

The Oncology Institute, Inc., an oncology company, provides various medical oncology services in the United States. The company operates through three segments: Dispensary, Patient Services, and Clinical Trials & Other. It offers physician services, in-house infusion and dispensary, clinical trial, radiation, outpatient blood product transfusion, and patient support services, as well as educational seminars, support groups, and counseling services. The company also provides managing clinical trials, palliative care programs, stem cell transplants services, and other care delivery models associated with non-community-based academic and tertiary care settings; and conducts clinical trials for a range of pharmaceutical and medical device companies. It serves adult and senior cancer patients. The company has a strategic collaboration with Healthly Forge to offer cancer care services to patients in Southern California. The Oncology Institute, Inc. was founded in 2007 and is headquartered in Cerritos, California.

About Auna

(Get Free Report)

Auna S.A., a healthcare service provider, operates hospitals and clinics in Mexico, Peru, and Colombia. The company provides prepaid healthcare plans in Peru; and dental and vision plans in Mexico. The company was founded in 1989 and is based in Luxembourg, Luxembourg.

Receive News & Ratings for Oncology Institute Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oncology Institute and related companies with MarketBeat.com's FREE daily email newsletter.